Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street

PLUR, CAT, NOC

Pre-open movers

U.S. stock futures traded higher in early pre-market trade. The housing market index for September is schedule for release at 10:00 a.m. ET.

Futures for the Dow Jones Industrial Average climbed 59 points to 22,278.00, while the Standard & Poor’s 500 index futures rose 5.25 points to 2,502.50. Futures for the Nasdaq 100 index gained 10.50 points to 6,005.75.

Oil prices traded lower as Brent crude futures fell 0.27 percent to trade at $55.47 per barrel, while US WTI crude futures dropped 0.12 percent to trade at $49.83 a barrel.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.69 percent, STOXX Europe 600 Index climbing 0.37 percent and German DAX 30 index gaining 0.34 percent. The UK's FTSE index was trading higher by 0.45 percent, while French CAC 40 Index rose 0.33 percent.

In Asian markets, Japan’s Nikkei Stock Average rose 0.52 percent, Hong Kong’s Hang Seng Index gained 1.27 percent, China’s Shanghai Composite Index rose 0.28 percent and India’s BSE Sensex climbed 0.47 percent.

Broker Recommendation

Analysts at UBS upgraded Caterpillar Inc. (NYSE: CAT) from Neutral to Buy.

Caterpillar shares rose 1.59 percent to $123.30 in pre-market trading.

Breaking news

  • Northrop Grumman Corporation (NYSE: NOC) announced plans to acquire Orbital ATK Inc (NYSE: OA) for $7.8 billion in cash.
  • Neos Therapeutics Inc (NASDAQ: NEOS) disclosed that it has received the FDA approval for Adzenys ER.
  • Nabriva Therapeutics plc (NASDAQ: NBRV) disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints.
  • Pluristem Therapeutics Inc. (NASDAQ: PSTI) disclosed that it has been granted FDA Fast Track Designation for PLX-PAD.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today